Table 1 Intracellular detection of TRAIL death receptors in human tissues
Tissue | Cell compartment a | TRAIL-R | Clinical relevance | Reference |
|---|---|---|---|---|
Colorectal carcinoma | Cytoplasm | 1, 2 | TRAIL-R1 is an independent prognostic marker for better prognosis | 18,19 |
Colorectal carcinoma | Cytoplasm | 1, 2 | Less progressive disease in high expressors of TRAIL-R1 during 5-FU therapy | 58 |
Colon cancer | Cytoplasm | 1, 2 | ND | 64 |
Breast cancer | Cytoplasm/nucleus | 1, 2 | TRAIL-R1 expression positively correlates with tumor grade | 60 |
Breast cancer | Cytoplasm | 1, 2 | High TRAIL-R2 expression correlates with poor prognosis | 20,21 |
Renal carcinoma | Cytoplasm | 2 | High TRAIL-R2 expression correlates with poor prognosis | 61 |
Non-small-cell lung cancer | Cytoplasm/nucleus | 2 | High TRAIL-R2 expression correlates with poor prognosis | 27 |
Non-small-cell lung cancer | Cytoplasm | 1, 2 | High TRAIL-R2 expression correlates with poor prognosis | 28 |
Non-small-cell lung cancer | Cytoplasm/nucleus | 2 | High expression of nuclear and cytoplasmic TRAIL-R2 correlates with improved patient survival | 68 |
Melanoma | Cytoplasm | 1, 2 | High TRAIL-R2 expression correlates with better prognosis | 62 |
Pancreatic ductal adenocarcinoma | Cytoplasm | 1, 2 | Plasma membrane expression of TRAIL-R2 correlates with better prognosis in patients without nodal metastases at the time of surgery | 17 |
Pancreatic ductal adenocarcinoma | Cytoplasm nucleus | 2 | High nuclear TRAIL-R2 expression correlates with poor prognosis of patients with early stages | 16 |
Glioblastoma multiforme | Cytoplasm | 1, 2 | High TRAIL-R1 expression correlates with better prognosis | 22 |
Head and neck squamous cell carcinoma | Cytoplasm | 2 | High TRAIL-R2 expression in primary tumors without metastasis correlates with better prognosis, but high TRAIL-R2 expression in tumors with metastasis correlates with worse prognosis | 23 |
Oral squamous cell carcinoma | Cytoplasm | 1, 2 | High TRAIL-R2 expression correlates positively with tumor size | 26 |
Cervical cancer | Cytoplasm | 1, 2 | High expression but no prognostic relevance | 24 |
Bladder cancer | Cytoplasm | 1, 2 | High TRAIL-R1 and -R2 expression correlates with better prognosis | 29 |
Normal and psoriatic skin lesions | Cytoplasm/nucleus | 1, 2 | ND | 70 |
CD16+, CD56+ and CD68+ cells in psoriatic skin lesions | Cytoplasm | 2 | ND | 70 |
CD4+ and CD8+ cells in psoriatic skin lesion | Nucleus | 1 | ND | 70 |